Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy

Radiopharmaceutical treatment of malignant pheochromocytoma.

Sisson Jc, Brahm Shapiro, Beierwaltes Wh et al. · PubMed · 1984 · 224 citations

Medicine, Endocrinology, Nuclear Medicine +13

The diagnostic and therapeutic utility of radioiodinated metaiodobenzy1guanidine (MIBG)

L Troncone, Vittoria Rufini, Paolo Montemaggi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1990 · 112 citations

Medicine, Nuclear Medicine, Radiology +14

Use of<i>m</i>-[¹³¹I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma

Michel Krempf, J. Lumbroso, R Mornex et al. · The Journal of Clinical Endocrinology & Metabolism · 1991 · 94 citations

Medicine, Nuclear Medicine, Pharmacology +14

Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.

Brahm Shapiro, James C. Sisson, D.M. Wieland et al. · PubMed · 1992 · 71 citations

Medicine, Oncology, Pharmacology +17

Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.

Valerie Lewington, Zivanovic Ma, M. Tristam et al. · PubMed · 1992 · 19 citations

Medicine, Nuclear Medicine, Oncology +14